165 related articles for article (PubMed ID: 29162888)
1. miR-500a-5p regulates oxidative stress response genes in breast cancer and predicts cancer survival.
Degli Esposti D; Aushev VN; Lee E; Cros MP; Zhu J; Herceg Z; Chen J; Hernandez-Vargas H
Sci Rep; 2017 Nov; 7(1):15966. PubMed ID: 29162888
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract][Full Text] [Related]
4. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
Tang W; Zhou W; Xiang L; Wu X; Zhang P; Wang J; Liu G; Zhang W; Peng Y; Huang X; Cai J; Bai Y; Bai L; Zhu W; Gu H; Xiong J; Ye C; Li A; Liu S; Wang J
Nat Commun; 2019 Feb; 10(1):663. PubMed ID: 30737378
[TBL] [Abstract][Full Text] [Related]
5. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
6. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.
Kim YS; Park SJ; Lee YS; Kong HK; Park JH
Oncotarget; 2016 Jul; 7(27):42261-42273. PubMed ID: 27304060
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
9. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Chang JT; Wang F; Chapin W; Huang RS
PLoS One; 2016; 11(12):e0168284. PubMed ID: 27959953
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation.
Pinho FG; Frampton AE; Nunes J; Krell J; Alshaker H; Jacob J; Pellegrino L; Roca-Alonso L; de Giorgio A; Harding V; Waxman J; Stebbing J; Pchejetski D; Castellano L
Cancer Res; 2013 Oct; 73(19):5936-48. PubMed ID: 23928990
[TBL] [Abstract][Full Text] [Related]
11. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
Hossain A; Kuo MT; Saunders GF
Mol Cell Biol; 2006 Nov; 26(21):8191-201. PubMed ID: 16940181
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-6744-5p promotes anoikis in breast cancer and directly targets NAT1 enzyme.
Malagobadan S; Ho CS; Nagoor NH
Cancer Biol Med; 2020 Feb; 17(1):101-111. PubMed ID: 32296579
[No Abstract] [Full Text] [Related]
16. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
17. NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.
Chen H; Yu C; Shen L; Wu Y; Wu D; Wang Z; Song G; Chen L; Hong Y
Pathol Res Pract; 2020 Dec; 216(12):153236. PubMed ID: 33038688
[TBL] [Abstract][Full Text] [Related]
18. Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis.
Aushev VN; Lee E; Zhu J; Gopalakrishnan K; Li Q; Teitelbaum SL; Wetmur J; Degli Esposti D; Hernandez-Vargas H; Herceg Z; Parada H; Santella RM; Gammon MD; Chen J
Clin Cancer Res; 2018 Feb; 24(3):581-591. PubMed ID: 29138345
[No Abstract] [Full Text] [Related]
19. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells.
Jiang L; Liu XQ; Ma Q; Yang Q; Gao L; Li HD; Wang JN; Wei B; Wen J; Li J; Wu YG; Meng XM
FASEB J; 2019 Mar; 33(3):3523-3535. PubMed ID: 30365367
[TBL] [Abstract][Full Text] [Related]
20. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
